Presentation Information
[O-44-2]Clinical trial of bosutinib for amyotrophic lateral sclerosis: iDReAM study
Haruhisa Inoue1, Keiko Imamura1, Takashi Ayaki3, Makiko Nagai4, Kazutoshi Nishiyama4, Yasuhiro Watanabe5, Ritsuko Hanajima5, Hiroshi Kataoka6, Takao Kiriyama6, Hitoki Nanaura6, Kazuma Sugie6, Takehisa Hirayama7, Osamu Kano7, Masahiro Nakamori8, Hirofumi Maruyama8, Koji Fujita2, Naoki Atsuta9, Gen Sobue10, Ryosuke Takahashi3, Yuishin Izumi2 (1.Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan, 2.Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, Japan, 3.Department of Neurology, Graduate School of Medicine, Kyoto University, Japan, 4.Department of Neurology, Kitasato University School of Medicine, Japan, 5.Division of Neurology, Department of Brain and Neurosciences, Faculty of Medicine, Tottori University, Japan, 6.Department of Neurology, Nara Medical University School of Medicine, Japan, 7.Department of Neurology, Toho University Faculty of Medicine, Japan, 8.Department of Clinical Neuroscience and Therapeutics, Graduate School of Biomedical and Health Sciences, Hiroshima University, Japan, 9.Department of Neurology, Aichi Medical University, Japan, 10.Aichi Medical University, Japan)